BERETTA, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 16.636
AS - Asia 10.880
EU - Europa 6.560
SA - Sud America 1.443
Continente sconosciuto - Info sul continente non disponibili 741
AF - Africa 221
OC - Oceania 9
Totale 36.490
Nazione #
US - Stati Uniti d'America 15.788
SG - Singapore 3.764
VN - Vietnam 2.431
IT - Italia 1.939
CN - Cina 1.887
HK - Hong Kong 1.178
BR - Brasile 1.089
RU - Federazione Russa 1.038
DE - Germania 804
SE - Svezia 665
CA - Canada 653
IE - Irlanda 413
GB - Regno Unito 399
BD - Bangladesh 375
UA - Ucraina 291
FR - Francia 280
IN - India 264
FI - Finlandia 176
KR - Corea 153
AR - Argentina 130
TR - Turchia 130
ID - Indonesia 111
ES - Italia 97
NL - Olanda 95
IQ - Iraq 92
MX - Messico 90
AT - Austria 86
JP - Giappone 76
ZA - Sudafrica 68
CO - Colombia 61
PL - Polonia 59
PK - Pakistan 50
VE - Venezuela 48
PH - Filippine 46
EC - Ecuador 44
SA - Arabia Saudita 44
UZ - Uzbekistan 42
BE - Belgio 37
DK - Danimarca 31
EG - Egitto 31
LT - Lituania 28
MY - Malesia 26
CR - Costa Rica 24
CH - Svizzera 23
MA - Marocco 23
CL - Cile 22
CZ - Repubblica Ceca 22
KE - Kenya 21
TH - Thailandia 21
IR - Iran 19
AE - Emirati Arabi Uniti 16
JM - Giamaica 16
JO - Giordania 16
PY - Paraguay 16
NP - Nepal 14
TN - Tunisia 14
LB - Libano 13
PE - Perù 13
AZ - Azerbaigian 12
ET - Etiopia 12
OM - Oman 12
UY - Uruguay 12
DZ - Algeria 11
GT - Guatemala 11
IL - Israele 11
KG - Kirghizistan 11
DO - Repubblica Dominicana 10
SN - Senegal 10
HN - Honduras 9
EE - Estonia 8
GR - Grecia 8
HU - Ungheria 8
MN - Mongolia 8
AL - Albania 7
BG - Bulgaria 7
NI - Nicaragua 7
PS - Palestinian Territory 7
AU - Australia 6
EU - Europa 6
GE - Georgia 6
KZ - Kazakistan 6
PA - Panama 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BO - Bolivia 5
RO - Romania 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
HR - Croazia 4
KH - Cambogia 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
MD - Moldavia 4
PR - Porto Rico 4
SV - El Salvador 4
TG - Togo 4
TT - Trinidad e Tobago 4
AM - Armenia 3
Totale 35.690
Città #
Singapore 1.846
Ashburn 1.828
Ann Arbor 1.382
San Jose 1.247
Hong Kong 1.137
Hanoi 693
Ho Chi Minh City 681
Chandler 644
Woodbridge 637
Milan 604
Houston 523
Fairfield 517
Frankfurt am Main 455
Toronto 446
Santa Clara 428
Los Angeles 425
Dallas 407
New York 403
Dublin 402
Council Bluffs 385
Jacksonville 309
Wilmington 286
Hefei 278
Seattle 259
Chicago 254
Beijing 250
The Dalles 223
Dearborn 216
Cambridge 202
Princeton 177
Rome 162
Buffalo 143
Seoul 143
Boardman 136
Columbus 129
Hangzhou 123
Lauterbourg 122
Shanghai 117
São Paulo 110
Da Nang 102
Phoenix 86
Moscow 85
Orem 84
Nanjing 78
Helsinki 76
Altamura 74
Jakarta 73
Munich 70
Lawrence 68
Haiphong 65
Nuremberg 65
Montreal 63
Tokyo 61
Brooklyn 60
Denver 58
Atlanta 57
London 56
San Diego 56
Guangzhou 52
Dong Ket 51
Lachine 51
Warsaw 47
Vienna 46
Hải Dương 44
Biên Hòa 43
San Francisco 42
Baghdad 41
Figino 38
Quận Bình Thạnh 37
Mountain View 36
Tashkent 36
Brussels 35
Can Tho 35
Rio de Janeiro 35
Shenyang 35
Poplar 34
Thái Nguyên 34
Manchester 33
Quận Một 33
Turin 33
Dhaka 32
Johannesburg 31
Philadelphia 31
Fremont 30
Nanchang 30
Salt Lake City 30
Stockholm 30
Mexico City 29
Boston 28
Naples 28
Hebei 27
Vũng Tàu 27
Andover 26
Turku 26
Amsterdam 25
Ninh Bình 25
Washington 25
Istanbul 24
Bắc Giang 23
Changsha 22
Totale 21.486
Nome #
Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke 1.123
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 606
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 568
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 507
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment 471
Prognostic Value of Signal Abnormalities on Brain MRI in Post-Anoxic Super-Refractory Status Epilepticus: A Single-Center Retrospective Study 455
The role of clinical and neuroimaging features in the diagnosis of CADASIL 454
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 426
Guillain-Barré syndrome related to COVID-19 infection 413
Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network 412
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 407
Implementation of continuous qEEG in two neurointensive care units by intensivists: a feasibility study 393
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 389
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 384
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 383
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 378
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 378
Incidence and predictors of acute symptomatic seizures after stroke 377
Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection 375
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 370
Intracranial collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 361
Intracranial Collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 342
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 340
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 340
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 339
Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment 335
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 333
Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease 332
Topographical and morphological patterns of post reperfusion molecular penumbra 331
Impact of COVID-19 on functional, cognitive, neuropsychiatric, and health-related outcomes in patients with dementia: A systematic review 326
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 326
Prognostic patterns and predictors in epilepsy: A multicentre study (PRO-LONG) 326
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 318
Therapeutic modulation of intracranial collateral flow improves outcome in experimental ischemic stroke 318
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 314
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study 313
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy 313
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 313
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 312
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 309
Absence and reappearance of N20 response after thiopental withdrawal in postanoxic coma 309
Guillain–Barré Syndrome Associated with COVID-19 303
Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection 297
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 290
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 290
Thermal plantar test in experimental ischemic stroke 289
Clinical factors associated with statins prescription in acute ischemic stroke patients: Findings from the Lombardia Stroke Registry 288
A multidisciplinary approach to screen the post-COVID-19 conditions 287
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 284
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 283
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 281
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 280
Experimental in-vivo model of intravascular shunting for neurosurgical bypass 280
Intracranial collateral flow in experimental ischemic stroke. From hemodynamic monitoring to collateral therapeutics 278
Cerebral collateral circulation in experimental ischemic stroke 278
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 274
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 272
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 272
Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series 272
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 269
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: The ICARO-2 study 265
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 258
Chapter 16. Impact of COVID-19 on pre-existing neurological diseases 257
Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network 256
The THRombolysis and STatins (THRaST) study 254
Guillain-Barré syndrome AMSAN variant in a 90-year-old woman after COVID-19: a case report 251
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW) 247
Optimized system for cerebral perfusion monitoring in the rat stroke model of intraluminal middle cerebral artery occlusion 247
Enhanced recovery strategies in colorectal surgery: is the compliance with the whole program required to achieve the target? 243
Double antiglutamatergic therapy in a case of postanoxic super-refractory status epilepticus 241
Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study 238
Discontinuation of antiseizure medications in seizure-free patients with long-term follow-up: Patients’ profile, seizure recurrence, and risk factors 235
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 234
Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol 233
From observation to monitoring: implementation of quantitative electroencephalography (QEEG) in neurointensive care 232
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 231
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 227
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 223
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 222
Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): A pragmatic randomised trial 222
Head-down tilt 15° increases cerebral perfusion before recanalization in acute ischemic stroke. A pre-clinical MRI study 216
Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients 216
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 215
Pharmacological manipulation of glutamate transport 210
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 208
Brain ultrasound rehearsal before surgery: A pilot cadaver study 207
Peripheral markers of glutamatergic dysfunction in neurological disease: focus on ex vivo tools 206
Spectral properties of the EEG during recovery of consciousness after acute brain injury 205
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 200
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 199
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 198
Head down positioning before recanalization in acute ischemic stroke 198
Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults 194
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 194
Elevated peripheral leukocyte counts in acute cervical artery dissection 192
COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy) 192
Quantitative EEG interpretation by EEG-naïve neurointensivists before and after expert training 189
Pathogenesis of retinal ganglion cell death in Leber hereditary optic neuropathy (LHON): possible involvement of mitochondria, light and glutamate 188
Possible neuroprotective strategies in ALS 188
Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke: Rationale and Study Protocol of a Multicenter, Randomized, Proof-of-Concept, Phase 2a/b Trial in Patients Treated With Mechanical Thrombectomy (DOWN-SUITE) 187
Totale 30.304
Categoria #
all - tutte 111.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022957 0 0 0 87 106 98 52 54 77 111 146 226
2022/20232.259 257 710 202 224 118 328 24 138 132 10 64 52
2023/20241.818 46 38 95 115 198 393 362 52 176 18 63 262
2024/20256.822 266 487 239 203 440 266 348 201 533 840 846 2.153
2025/202614.240 1.750 956 1.047 1.392 1.639 684 1.995 583 971 1.241 876 1.106
2026/20273.873 545 1.051 1.641 636 0 0 0 0 0 0 0 0
Totale 36.490